Effect of Currently Approved Carriers and Adjuvants on the Pre-Clinical Efficacy of a Conjugate Vaccine against Oxycodone in Mice and Rats

Por Pravetoni, Marco, Vervacke, Jeffrey S., Distefano, Mark D., Tucker, Ashli M., Laudenbach, Megan, Pentel, Paul R.
Publicado em 2014

Diazirine-Containing Photoactivatable Isoprenoid: Synthesis and Application in Studies with Isoprenylcysteine Carboxyl Methyltransferase

Por Vervacke, Jeffrey S., Funk, Amy L., Wang, Yen-Chih, Strom, Mark, Hrycyna, Christine A., Distefano, Mark D.
Publicado em 2014

Synthesis of Site-Specific DNA–Protein Conjugates and Their Effects on DNA Replication

Por Yeo, Jung Eun, Wickramaratne, Susith, Khatwani, Santoshkumar, Wang, Yen-Chih, Vervacke, Jeffrey, Distefano, Mark D., Tretyakova, Natalia Y.
Publicado em 2014

The Chaperone Protein SmgGDS Interacts with Small GTPases Entering the Prenylation Pathway by Recognizing the Last Amino Acid in the CAAX Motif

Por Schuld, Nathan J., Vervacke, Jeffrey S., Lorimer, Ellen L., Simon, Nathan C., Hauser, Andrew D., Barbieri, Joseph T., Distefano, Mark D., Williams, Carol L.
Publicado em 2014

The frequency of naïve and early-activated hapten-specific B cell subsets dictates the efficacy of a therapeutic vaccine against prescription opioid abuse

Por Laudenbach, Megan, Baruffaldi, Federico, Vervacke, Jeffrey S, Distefano, Mark D, Titcombe, Philip J, Mueller, Daniel L, Tubo, Noah J, Griffith, Thomas S, Pravetoni, Marco
Publicado no J Immunol (2015)